胸阻抗法無(wú)創(chuàng)血流動(dòng)力學(xué)監(jiān)測(cè)在心肺復(fù)蘇治療中的意義
發(fā)布時(shí)間：2018-12-05 20:44
【摘要】：目的：探討胸阻抗法無(wú)創(chuàng)血流動(dòng)力學(xué)監(jiān)測(cè)在心肺復(fù)蘇自主循環(huán)恢復(fù)的治療中對(duì)血管活性藥物應(yīng)用的指導(dǎo)作用，以及對(duì)心肺復(fù)蘇后患者臟器功能的保護(hù)意義。 方法：選取2012年1月-2012年12月期間與我院住院治療患者，既往無(wú)器質(zhì)性心臟病變及心功能障礙的突發(fā)心臟驟停，經(jīng)積極搶救后自主循環(huán)恢復(fù)且存活超過(guò)72小時(shí)患者13例。入選病例隨機(jī)分為實(shí)驗(yàn)組及對(duì)照組，實(shí)驗(yàn)組7例，對(duì)照組6例,各組病例在性別、年齡、體重方面差異無(wú)統(tǒng)計(jì)學(xué)意義，且與搶救治療同時(shí)積極治療原發(fā)病。實(shí)驗(yàn)組根據(jù)胸阻抗法無(wú)創(chuàng)血流動(dòng)力學(xué)監(jiān)測(cè)儀器測(cè)定CO值調(diào)整血管活性藥物的應(yīng)用時(shí)間及劑量，對(duì)照組根據(jù)外周血壓的變化按常規(guī)方法調(diào)整血管活性藥物應(yīng)用時(shí)間及劑量。各組均分別留取0分鐘、1h、6h、12h、24h，48h、72h監(jiān)測(cè)的CO、CI、SV、SI、ACI、VI、LVET、STR、PEP值；同時(shí)于各時(shí)間點(diǎn)留取靜脈血經(jīng)干化學(xué)法行化驗(yàn)檢查留取CK、CK-MB、hs-TnI及BNP值，留取動(dòng)脈血于床旁血?dú)夥治鰞x留取血LAC值;行床旁CVP檢查留取CVP值，并進(jìn)行GCS評(píng)分以評(píng)估患者腦神經(jīng)功能恢復(fù)情況。 結(jié)果：0min實(shí)驗(yàn)組及對(duì)照組數(shù)據(jù)監(jiān)測(cè)均無(wú)明顯統(tǒng)計(jì)學(xué)差異；1h實(shí)驗(yàn)組心率（HR）較對(duì)照組減少，P＜0.05,有統(tǒng)計(jì)學(xué)差異；6h、12h、24h、48h及72h實(shí)驗(yàn)組CO、CI、SV、SI、ACI、VI均高于對(duì)照組，P＜0.05，有統(tǒng)計(jì)學(xué)差異；12h、24h、48h及72h實(shí)驗(yàn)組LVET較對(duì)照組提高，P＜0.05，有統(tǒng)計(jì)學(xué)差異；6h、12h、24h、48h及72h實(shí)驗(yàn)組STR較對(duì)照組縮短，P＜0.05，有統(tǒng)計(jì)學(xué)差異；24h實(shí)驗(yàn)組PEP較對(duì)照組縮短，P0.05，有統(tǒng)計(jì)學(xué)差異；6h實(shí)驗(yàn)組CK較對(duì)照組減少，P＜0.05，有統(tǒng)計(jì)學(xué)差異；6h、12h、24h、48h及72h實(shí)驗(yàn)組CK-MB及hs-TnI與對(duì)照組比較，P0.05，無(wú)統(tǒng)計(jì)學(xué)差異。24h、48h、72h實(shí)驗(yàn)組BNP較對(duì)照組減少，P＜0.05，有統(tǒng)計(jì)學(xué)差異；6h、12h、24h、48h及72h實(shí)驗(yàn)組LAC較對(duì)照組減少，P＜0.05，有統(tǒng)計(jì)學(xué)差異；12h、24h、48h及72h實(shí)驗(yàn)組CVP較對(duì)照組減少，P＜0.05，有統(tǒng)計(jì)學(xué)差異；12h、24h、48h及72h實(shí)驗(yàn)組GCS較對(duì)照組提高，P＜0.05，有統(tǒng)計(jì)學(xué)差異。 結(jié)論：胸阻抗法無(wú)創(chuàng)血流動(dòng)力學(xué)動(dòng)態(tài)監(jiān)測(cè)可以有效指導(dǎo)心臟驟停后心肺復(fù)蘇過(guò)程中血管活性藥物的應(yīng)用，可以增加心臟供血，加速缺血缺氧受損心肌細(xì)胞的恢復(fù)，增加心肌射血功能，增加患者心排出量，減輕心衰程度，，促進(jìn)心功能的恢復(fù)；增加腦血流供應(yīng)，減少腦組織缺血時(shí)間，降低缺血再灌注時(shí)間，減少腦組織缺血再灌注損傷，保護(hù)腦神經(jīng)細(xì)胞，促進(jìn)患者腦功能的恢復(fù)；盡早降低血乳酸水平，減輕組織缺氧，有利于機(jī)體氧代謝的平衡和內(nèi)環(huán)境的穩(wěn)定，對(duì)心肺復(fù)蘇后患者臟器功能的保護(hù)有重要意義。促進(jìn)患者預(yù)后恢復(fù)。
[Abstract]:Objective: to investigate the guiding role of noninvasive hemodynamic monitoring in the treatment of spontaneous circulation recovery of cardiopulmonary resuscitation (CPR) and the significance of protecting organ function after cardiopulmonary resuscitation (CPR) in patients with cardiopulmonary resuscitation (CPR). Methods: from January 2012 to December 2012, 13 patients with sudden cardiac arrest without organic heart disease and cardiac dysfunction were selected. After active rescue, the spontaneous circulation recovered and survived for more than 72 hours. The patients were randomly divided into two groups: experimental group (n = 7) and control group (n = 6). There was no significant difference in sex, age and body weight between each group. The experimental group adjusted the time and dose of vasoactive drugs according to the noninvasive hemodynamic monitoring instrument of thoracic impedance method, and the control group adjusted the time and dose of vasoactive drugs according to the changes of peripheral blood pressure. The CO,CI,SV,SI,ACI,VI,LVET,STR,PEP values of each group were taken for 0 min, 1 h, 6 h, 12 h, 24 h, 48 h and 72 h, respectively. At the same time, the venous blood was collected at each time point by dry chemical method. The values of CK,CK-MB,hs-TnI and BNP were collected by laboratory examination, and the values of LAC were collected from arterial blood by the blood gas analyzer beside the bed. Bedside CVP was performed to measure the CVP value and GCS score was used to evaluate the recovery of cerebral nerve function. Results: there was no significant difference in monitoring data between the 0min group and the control group, and the heart rate (HR) in the experimental group was lower than that in the control group at 1 h (P < 0.05). The CO,CI,SV,SI,ACI,VI of the experimental group was significantly higher than that of the control group (P < 0.05), and the LVET of the experimental group was significantly higher than that of the control group (P < 0.05). The STR of the experimental group was shorter than that of the control group (P < 0.05), the PEP of the experimental group was shorter than that of the control group (P < 0.05), and the PEP of the experimental group at 24 h was shorter than that of the control group (P 0.05). The CK of the experimental group was significantly lower than that of the control group at 6 h (P < 0.05). There was no significant difference in CK-MB and hs-TnI between the experimental group and the control group at 12 and 72 hours (P < 0.05), but the BNP in the experimental group was lower than that in the control group at 24 h and 48 h and 72 h (P < 0.05), there was statistical difference between the experimental group and the control group (P < 0.05). The LAC of the experimental group was significantly lower than that of the control group (P < 0.05), and the CVP of the experimental group was lower than that of the control group (P < 0.05) at 24 h and 72 h, respectively. The GCS of the experimental group was significantly higher than that of the control group at 24 h and 72 h (P < 0.05). Conclusion: Non-invasive dynamic monitoring of hemodynamics by thoracic impedance method can effectively guide the application of vasoactive drugs during cardiopulmonary resuscitation after cardiac arrest, increase the blood supply to the heart and accelerate the recovery of myocardial cells damaged by ischemia and hypoxia. Increase myocardial ejection function, increase cardiac output, reduce heart failure, promote the recovery of cardiac function; Increase cerebral blood flow, reduce cerebral ischemia time, reduce ischemia-reperfusion time, reduce cerebral ischemia reperfusion injury, protect brain nerve cells, promote the recovery of brain function. Reducing blood lactic acid level and tissue hypoxia as early as possible is beneficial to the balance of oxygen metabolism and stability of internal environment. It is of great significance for the protection of organ function after cardiopulmonary resuscitation (CPR). To promote the recovery of prognosis.
【學(xué)位授予單位】：大連醫(yī)科大學(xué)
【學(xué)位級(jí)別】：碩士
【學(xué)位授予年份】：2013
【分類(lèi)號(hào)】：R459.7
本文編號(hào)：2365445
[Abstract]:Objective: to investigate the guiding role of noninvasive hemodynamic monitoring in the treatment of spontaneous circulation recovery of cardiopulmonary resuscitation (CPR) and the significance of protecting organ function after cardiopulmonary resuscitation (CPR) in patients with cardiopulmonary resuscitation (CPR). Methods: from January 2012 to December 2012, 13 patients with sudden cardiac arrest without organic heart disease and cardiac dysfunction were selected. After active rescue, the spontaneous circulation recovered and survived for more than 72 hours. The patients were randomly divided into two groups: experimental group (n = 7) and control group (n = 6). There was no significant difference in sex, age and body weight between each group. The experimental group adjusted the time and dose of vasoactive drugs according to the noninvasive hemodynamic monitoring instrument of thoracic impedance method, and the control group adjusted the time and dose of vasoactive drugs according to the changes of peripheral blood pressure. The CO,CI,SV,SI,ACI,VI,LVET,STR,PEP values of each group were taken for 0 min, 1 h, 6 h, 12 h, 24 h, 48 h and 72 h, respectively. At the same time, the venous blood was collected at each time point by dry chemical method. The values of CK,CK-MB,hs-TnI and BNP were collected by laboratory examination, and the values of LAC were collected from arterial blood by the blood gas analyzer beside the bed. Bedside CVP was performed to measure the CVP value and GCS score was used to evaluate the recovery of cerebral nerve function. Results: there was no significant difference in monitoring data between the 0min group and the control group, and the heart rate (HR) in the experimental group was lower than that in the control group at 1 h (P < 0.05). The CO,CI,SV,SI,ACI,VI of the experimental group was significantly higher than that of the control group (P < 0.05), and the LVET of the experimental group was significantly higher than that of the control group (P < 0.05). The STR of the experimental group was shorter than that of the control group (P < 0.05), the PEP of the experimental group was shorter than that of the control group (P < 0.05), and the PEP of the experimental group at 24 h was shorter than that of the control group (P 0.05). The CK of the experimental group was significantly lower than that of the control group at 6 h (P < 0.05). There was no significant difference in CK-MB and hs-TnI between the experimental group and the control group at 12 and 72 hours (P < 0.05), but the BNP in the experimental group was lower than that in the control group at 24 h and 48 h and 72 h (P < 0.05), there was statistical difference between the experimental group and the control group (P < 0.05). The LAC of the experimental group was significantly lower than that of the control group (P < 0.05), and the CVP of the experimental group was lower than that of the control group (P < 0.05) at 24 h and 72 h, respectively. The GCS of the experimental group was significantly higher than that of the control group at 24 h and 72 h (P < 0.05). Conclusion: Non-invasive dynamic monitoring of hemodynamics by thoracic impedance method can effectively guide the application of vasoactive drugs during cardiopulmonary resuscitation after cardiac arrest, increase the blood supply to the heart and accelerate the recovery of myocardial cells damaged by ischemia and hypoxia. Increase myocardial ejection function, increase cardiac output, reduce heart failure, promote the recovery of cardiac function; Increase cerebral blood flow, reduce cerebral ischemia time, reduce ischemia-reperfusion time, reduce cerebral ischemia reperfusion injury, protect brain nerve cells, promote the recovery of brain function. Reducing blood lactic acid level and tissue hypoxia as early as possible is beneficial to the balance of oxygen metabolism and stability of internal environment. It is of great significance for the protection of organ function after cardiopulmonary resuscitation (CPR). To promote the recovery of prognosis.
【學(xué)位授予單位】：大連醫(yī)科大學(xué)
【學(xué)位級(jí)別】：碩士
【學(xué)位授予年份】：2013
【分類(lèi)號(hào)】：R459.7
【參考文獻(xiàn)】
相關(guān)期刊論文 前10條
1 韋玉文,王衛(wèi)國(guó),陳端睢,何其練,楊春萬(wàn);無(wú)創(chuàng)血流動(dòng)力學(xué)監(jiān)測(cè)系統(tǒng)在ICU的綜合應(yīng)用分析[J];國(guó)際醫(yī)藥衛(wèi)生導(dǎo)報(bào);2004年10期
2 趙冰清;陳宇清;周新;鄭明芳;;無(wú)創(chuàng)正壓通氣支持對(duì)慢性呼吸衰竭患者血流動(dòng)力學(xué)參數(shù)的影響[J];國(guó)外醫(yī)學(xué).呼吸系統(tǒng)分冊(cè);2005年12期
3 劉海健;張謙;周厚榮;楊嬌榮;吳明;;心肺復(fù)蘇后心功能不全研究進(jìn)展[J];貴州醫(yī)藥;2010年01期
4 聶紹良;李曉葵;;B型鈉尿肽在心肺復(fù)蘇患者中變化的臨床意義[J];臨床軍醫(yī)雜志;2010年02期
5 肖敏;呂軍;;心跳驟停復(fù)蘇后綜合征的研究[J];內(nèi)科急危重癥雜志;2009年01期
6 王忠勇;;心臟驟停心肺復(fù)蘇模型中血氧與血乳酸濃度監(jiān)測(cè)的價(jià)值[J];南通醫(yī)學(xué)院學(xué)報(bào);2009年06期
7 劉哲;宋曉東;惠汝太;;B型鈉尿肽最新研究進(jìn)展[J];心血管病學(xué)進(jìn)展;2009年01期
8 賴(lài)榮德;梁子敬;;心肺復(fù)蘇臨床研究進(jìn)展[J];醫(yī)學(xué)研究雜志;2010年04期
9 戴曉勇;岑烈;顏伶;楊曉英;俞斌;華瑋;;35例慢性心力衰竭患者無(wú)創(chuàng)血流動(dòng)力學(xué)監(jiān)測(cè)與腦利鈉肽水平相關(guān)性研究[J];中國(guó)醫(yī)藥指南;2009年02期
10 馬彩娥,李平,呂發(fā)勤,杜莉,孔軍;超聲心動(dòng)圖評(píng)價(jià)腎移植前后心功能變化[J];中華超聲影像學(xué)雜志;2000年09期
本文編號(hào)：2365445
本文鏈接：http://www.sikaile.net/yixuelunwen/jjyx/2365445.html
最近更新
教材專(zhuān)著
